Agility
adds value

ーTEIJIN REGENET Co., Ltd.

Creating a Future
for Regenerative Medicine

ーJapan Tissue
Engineering Co., Ltd.

TEIJIN CDMO, jointly operated by TEIJIN REGENET and J-TEC, offers CDMO service for cell & gene therapy as well as regenerative medicine.

TEIJIN REGENET Co., Ltd.
Japan Tissue Engineering Co., Ltd.

Latest News

TEIJIN CDMO's strength

One-stop solution for manufacturing of cell based products

Accomplishments of 5 regulatory approvals in regenerative medicine

※As of April 2024

Supports of vector manufacturing and overseas clinical trials

Learn more

CDMO services

Facilities

News

Questionnaire
about your needs

Please share your needs for process development, manufacturing,
analysis in cell & gene therapies/regenerative medicines.
(About 5 min)

Answer the questionnaire

Blog and Topics

Driving cross-border innovation to bring advanced therapies closer to patients in the Asia-Pacific region
Pickup

Oct. 09. 2025

Topics

◆Interview : BioPharma APAC "Teijin and Cell Therapies Forge a Cross-Border Alliance to Accelerate CGT Access Between Japan and Australia"
Exhibition Report : INTERPHEX Week TOKYO2025 / Regenerative Medicine EXPO
Pickup

Jul. 18. 2025

Blog

Exhibition Report : INTERPHEX Week TOKYO2025 / Regenerative Medicine EXPO
Teijin Regenet, TOHO HOLDINGS and ITOCHU Corp. Enter into Business Alliance Aimed at Building Novel Regenerative Medicine Ecosystem
NEW

Jul. 10. 2025

Topics

Teijin Regenet, TOHO HOLDINGS and ITOCHU Corp. Enter into Business Alliance Aimed at Building Novel Regenerative Medicine Ecosystem
How to maximize chances of success when expanding your CGT&RM portfolio into Japan
Pickup

Aug. 14. 2023

Blog

<Blog 5>How to maximize chances of success when expanding your CGT&RM portfolio into Japan

View all